Special News Update:

In today’s pharmaceutical market, costly drug recalls can be avoided. This special article focuses on the recent Johnson & Johnson recall of more than 40 over-the-counter pediatric medicines, and how Raman spectroscopy and chemical imaging can help prevent similar events from happening in the future.

Quality Control: An Important Issue in Recent
Johnson & Johnson Drug Recall

Pharmaceutical drug manufacturing recalls, like the recent  Johnson & Johnson/McNeil plant recall of infant and children’s Tylenol®, Benadryl® and other over-the-counter meds,  can cause consumer concern, as well as be detrimental to a company’s financial well being and damage its public image. Marking the fourth recall in the past year, Johnson & Johnson’s production methods are currently under investigation by the House Committee on Oversight and Government Reform.

The reason for this particular recall points to quality control. It’s suspected that the more than 40 pediatric medicines may contain a host of different issues including: a higher concentration of the active ingredient than specified, inactive ingredients that may not meet internal testing requirements, contaminated starting materials and foreign particles.

> Read full article